Join our list for exclusive deals, VIP-only launches, and special offers made just for you. 🎉
The non-surgical options for sex after prostate surgery fall into two groups. The first group works by producing or supporting a biological erection, and it includes oral medication, vacuum erection devices, urethral suppositories, and penile injections, sometimes alongside a penile rehabilitation program, pelvic floor therapy, or shockwave therapy. Everything in that group depends on nerve signaling that can take one to two years to recover and may never fully return. The second group supplies rigidity from the outside and works with no erection at all, which is what an external penile prosthesis, or penis sleeve, like an RX Sleeve does. None of these restores natural erectile function, and none of them rules out the others. Several can be used together.
We have been making external penile prostheses at RX Sleeve since 2004, and men recovering from prostate surgery have been a core group of our customers from the start. Our founder, Dan Tomlinson, designed surgical displays for hospitals before he started the company. We sell one of the options below and none of the others, and most of what follows has nothing to do with our products. It is what twenty years of answering the same questions taught us, and the answer starts with why the pills stopped working.
This guide is for men after radical prostatectomy. If you had radiation, the mechanical options work much the same way, though your timeline and nerve picture differ. Two things are worth saying up front. Pill failure after surgery is anatomical, not personal, and it does not predict how the other options will go. And orgasm is still possible without an erection.
Almost every man has some degree of erectile dysfunction in the first months after prostate cancer treatment, and Johns Hopkins Medicine describes that as close to universal. Recovery after nerve-sparing surgery can take two years or longer, so an early failure on medication proves nothing about where you end up. Waiting also guarantees nothing.
Three things drive erectile recovery after prostate surgery.
A 3% to 44% spread across surgeons is why another man's outcome makes a poor benchmark for yours. A man in his fifties, a year out from bilateral nerve-sparing surgery, has real reason to keep working at oral therapy and give it more time. A man of 72, two years out from non-nerve-sparing surgery, is asking a different question, and telling him to be patient is not an answer.
Most surgical teams clear men to resume sexual activity somewhere around four to six weeks, and UCSF's patient guidance advises allowing at least that long after surgery. Your own date comes from your surgeon, not from an article. Clearance is about healing, and it tells you nothing about whether anything will work yet.
PDE5 inhibitors such as sildenafil, tadalafil, vardenafil, and avanafil do not create an erection. They slow the breakdown of a chemical messenger that erectile tissue produces in response to a nerve signal, which amplifies a signal that is already there. Radical prostatectomy can damage or remove the cavernous nerves that supply that signal. After nerve injury there is less signal to amplify, so the drug has less to work with. That is the whole explanation.
The numbers track nerve-sparing status closely. A cohort of 174 men prescribed sildenafil after radical prostatectomy reported successful intercourse at very different rates depending on what the surgery preserved.
| Surgery type | Men reporting successful intercourse |
|---|---|
| Bilateral nerve-sparing | 79 of 104 (76%) |
| Unilateral nerve-sparing | 15 of 28 (53.5%) |
| Non-nerve-sparing | 6 of 42 (14.2%) |
Overall that came to roughly 57%. Non-nerve-sparing surgery cut the sildenafil response to 14.2%, far lower, but not zero. A separate group of 120 men who started sildenafil at least 12 months after surgery showed an overall response closer to 29%, which is a reminder that late starts and differently selected groups produce very different numbers.
Two practical points men get wrong. A pill taken without sexual stimulation is not a valid test. And nitrates are incompatible with PDE5 inhibitors, because the combination can drop blood pressure dangerously, so anyone on nitrate medication needs a different path. Sildenafil is also blunted by a heavy meal.
Daily dosing is often presented as rehabilitation. The REACTT trial randomized 423 men to daily tadalafil, on-demand tadalafil, or placebo for nine months. After a six-week drug-free washout, the proportions reaching a normal erectile function score were 20.9%, 16.9%, and 19.1%, which is not a meaningful difference. Daily treatment did improve function while it was being taken, and it reduced measured length loss compared with placebo by 4.1 mm at nine months. A drug that works while you take it has not given you your own erections back.
A vacuum erection device draws blood into the penis mechanically, and a constriction ring at the base holds it there for intercourse. The pump does not need your nerves to work, so a failure on pills tells you nothing about whether a pump will.
There are two different uses of the same device. Pumping without the ring is rehabilitation, done to keep tissue oxygenated. Pumping with the ring is how you get an erection for sex. Mayo Clinic and NIDDK both cover the mechanics in detail.
In a randomized study of 109 men after prostatectomy, 74 were assigned to a vacuum device and 35 to observation. Over nine months, 60 of the 74 men (about 81%) used the device successfully for intercourse. Among those 60 successful users, 33 partners (55%) reported satisfaction. Fourteen of the 74 (about 19%) had stopped by a mean of three months. Rigidity is the easy thing to measure, and the satisfaction number sits a long way below it.
Post-prostatectomy samples report steep attrition, with one showing 39% still using at one year and 5% at five years, and another in which 92% of men found the device effective but only 14% kept using it at home. It works. Most men stop.
The trade-offs men actually report are setup time, a penis that feels cool or numb, occasional bruising, and an erection that pivots at the base and feels different from their own.
Almost every article on this topic gets this wrong. You will read that these devices carry a 30-minute limit. That limit belongs to the constriction ring, which should not stay on longer than 30 minutes because it restricts blood flow. It says nothing about external devices generally. An external penile prosthesis does not restrict blood flow and has no wear duration limit. We have written a fuller comparison of vacuum devices and sleeves for men weighing the two.
The two also work together. A sleeve can be worn over whatever erection a pump produces, and it is what men reach for on nights when setting up the pump is not practical.
On cost, this is the option where the guidance in circulation is most out of date. Medicare's current coverage policy lists vacuum erection devices and their accessories as statutorily non-covered, effective July 1, 2015. Any page telling you Medicare pays 80% for a prescribed pump is describing a benefit that no longer exists.
An intraurethral alprostadil pellet is inserted into the urethra after urinating and absorbed locally, relaxing the erectile tissue directly. Like injections, it does not depend on the upstream nerve signal that a pill needs.
In a post-surgical randomized comparison, 139 men received nightly intraurethral alprostadil and 73 received nightly sildenafil. Non-completion ran to 30.2% in the suppository group and 19.2% in the sildenafil group, with no significant difference in the main end-of-treatment comparisons. Urethral or penile burning, minor bleeding, and dizziness are the common reasons men stop, and a first dose is usually given under supervision.
Branded MUSE is no longer on the shelf, and that changes the decision. ASHP reports that Viatris discontinued it in June 2024, with all three strengths listed as unavailable as of August 2024. Most articles ranking for this topic still present it as a routine next step. Compounded urethral preparations do exist, but they are different products with different formulations and their own evidence, and they are not automatically interchangeable with the studied suppository.
Injections put the drug where it acts. Alprostadil alone, or a compounded combination such as Bimix or Trimix, goes into the erectile tissue with a very fine needle and relaxes the smooth muscle directly. UCSF states plainly in its patient guidance that injections can work after non-nerve-sparing surgery. For a man whose surgery took both bundles, this is often the option with the best odds.
Effectiveness in the published series is high. An early observational study of 168 men aged 43 to 78 after prostatectomy reported success in 94.6% using a self-injected combination, though that was a selected and uncontrolled group rather than a contemporary comparative rate.
The more useful data is about living with them. An eight-year survey of men after prostatectomy found that 140 of 368 respondents had ever used injections, and only 34 of those 140 (24%) were still using them at eight years. Overall satisfaction among respondents ran to 44%. The reasons for stopping, which overlap, were:
Nearly one in five men stopped injections because his own erections came back, which makes some of that dropout the best result on the list.
Prescription, dose titration, and hands-on training are all required. Memorial Sloan Kettering's patient guide typically uses two teaching visits and instructs patients not to adjust their own dose, and Trimix generally needs refrigeration. An erection lasting four hours is a medical emergency, and your clinic should give you an action plan that starts well before that. In a 2023 post-surgical program that combined Trimix with prescribed oral therapy, priapism occurred in 1.7% and 1.4% of two groups, with erections lasting two hours or more in 6.3% and 3.3%. More than half of the prolonged events happened within the first six injections, which is why supervised titration matters.
Penile rehabilitation means taking pro-erectile treatment on a schedule after surgery, usually daily or scheduled PDE5 inhibitors and sometimes a pump, on the theory that keeping tissue oxygenated protects it while the nerves recover.
The evidence for that theory is weaker than the enthusiasm around it. A Cochrane review of eight randomized trials and 1,699 participants found that scheduled PDE5 inhibitors compared with placebo or no treatment gave a potency risk ratio of 1.13, with a confidence interval from 0.91 to 1.41 that crosses no effect. Scheduled versus on-demand use came out at 0.97. The certainty of the evidence was rated very low.
Adherence is the other limitation. In one rehabilitation cohort, 55.8% of men were still in the program at 12 months and 45% at 24 months, with cost, inconvenience, and a sense that it was not working cited as the barriers.
Early treatment helps you have sex now, which is worth something on its own, but it has not been shown to improve your odds of getting unassisted erections back. Be skeptical of a use-it-or-lose-it guarantee, and equally skeptical of anyone calling rehabilitation pointless. There is no standard package. A rehabilitation program is the sum of medicines, devices, and visits, with no single coverage status.
Pelvic floor muscle training is usually offered for continence, and that is where its strongest justification sits. The erectile evidence is genuinely mixed. A systematic review published in August 2026 included 12 randomized trials, of which four showed a significant erectile benefit and seven did not. One favorable trial reported 12-month potency of 47.1% against 12.5% in controls, but that is a single trial rather than a pooled rate, and heterogeneity across the studies limited confidence in all of it.
A well-conducted 2020 trial of 97 men illustrates the pattern. Early pelvic floor training improved quality of life and sped up continence recovery, but the 12-week protocol was not powerful enough to demonstrate an erectile benefit.
For a man dealing with leakage during sex, that continence effect is often what decides whether he is willing to try at all. You do not need a prescription to learn the exercises, though doing them correctly is harder than it sounds and most men benefit from being taught. Medicare Part B covers medically necessary outpatient physical therapy under a certified plan, with the usual 20% patient share after the deductible, which is not the same as automatic approval for an erectile rehabilitation package.
Shockwave therapy is marketed heavily to men after prostate surgery, and the evidence behind it is thinner than the marketing.
A meta-analysis published in July 2026 pooled five randomized trials in men after prostatectomy, covering 297 men. It found improvements of roughly 2.8 and 2.1 points on the erectile function questionnaire at 8 and 12 weeks, and no significant benefit at 24 weeks or beyond. A small, temporary change in a questionnaire score is not evidence of nerve regeneration.
The AUA's 2018 erectile dysfunction guideline classifies low-intensity extracorporeal shockwave therapy as investigational, a conditional recommendation supported by Grade C evidence, and we found no superseding position. The Sexual Medicine Society of North America reserves restorative therapies for clinical trials. Protocols and machines vary widely between clinics, and focused low-intensity shockwaves are not equivalent to the radial pressure-wave devices some providers use.
None of that makes it useless. It makes it a cash-pay experiment with clinic visits attached, and it should not be handed to you as the obvious next step after pills.
Testosterone is not a treatment for surgically damaged erection nerves, and no reputable clinician should present it as one. It is considered for men with symptoms plus biochemically confirmed low testosterone, with cancer history and current PSA central to the decision. It is not appropriate during androgen deprivation therapy or with active disease.
A randomized trial published in 2026 is the most decision-relevant evidence available. It enrolled 136 men, mean age 68.6, after prostatectomy for organ-confined disease, all with undetectable PSA for at least two years and two low testosterone measurements. Over 12 weeks, testosterone increased sexual activity by 0.91 daily events compared with placebo and improved desire. Erectile function did not change. No biochemical recurrence occurred in either group, though 12 weeks cannot settle long-term oncologic safety.
Testosterone can move desire and activity for a man who is genuinely deficient. It will not give you an erection back.
An external penile prosthesis is worn over the penis and supplies rigidity mechanically. If the category is new to you, we explain how these devices work here. The practical difference from everything above is that it does not require an erection, a nerve signal, a drug, or a recovery window. It works the same on month three as on year three.
We want to be straight about the evidence, because our own category is the one with the least of it. The peer-reviewed literature discusses external prostheses and supportive sleeves as a way to have penetrative sex without a rigid biological erection, and describes the published material as case reports and anecdotal accounts rather than trials. There is no efficacy rate, no dropout rate, no adverse event rate, and no partner satisfaction dataset for sleeves. Anyone who quotes you one is making it up. What exists is a clear mechanical rationale and a long history of use.
Acceptance has been studied, if not outcomes. A 2022 survey of 147 men with erectile dysfunction, 62.6% of whom developed it after a procedure such as prostatectomy or radiation, found that willingness to consider an external penile prosthesis rose significantly as men were given more information, and correlated with partner involvement. One caveat travels with it. The device tested was a harness-mounted external phallic device rather than a sleeve.
These devices are under-discussed rather than hidden. A 2017 urology editorial describes non-medical alternatives as poorly known and poorly covered, and most guideline and cancer center materials move from drugs to pumps to injections to implants. Meanwhile the Prostate Cancer Foundation notes that only around 2% of men go on to a surgical penile implant after prostatectomy, despite high satisfaction among those who do. That leaves a very large group of men sitting between "the pills stopped working" and "I am not having another operation."
On regulation, 21 CFR 876.5020 defines external penile rigidity devices and classifies them as Class II, a category that also covers vacuum pumps, constriction rings, and splints. RX Sleeve is FDA-listed as a Class II External Penile Rigidity Device. Listing is a regulatory registration, not an FDA approval or endorsement, and no manufacturer in this category should tell you otherwise.
Four things separate a device that works for a post-surgical man from one that does not.
Realism is what men and their partners judge us on first, and it comes out of the material and the handwork. Our sleeves are handmade in the USA from certified skin-safe, platinum-cured, medical-grade* silicone, which is also why they last years rather than months. Standard models run $299 to $525, custom builds are higher, and they are FSA, HSA, and HRA eligible.
Two honest limits. Sensation varies from man to man, depending on post-surgical status, the treatments you have had, and blood flow, and we will not promise you a number. And a device gives you the physical means to be intimate. It does not guarantee orgasm for you or for your partner.
Using a sleeve alongside other treatments is covered in the section on combining options below. For help choosing between models, we have a full guide to selecting a sleeve after prostate surgery.
| Option | What it requires | How soon after surgery | Prescription | Rough cost |
|---|---|---|---|---|
| Oral PDE5 inhibitors | Nerve signal to amplify, plus sexual stimulation | Often started within days of catheter removal | Yes | About $696 a year in a published model, far less with generics |
| Vacuum erection device | Manual setup before sex, constriction ring for intercourse | Commonly 4 to 6 weeks, earlier without the ring for rehabilitation | Some models over the counter | About $213 per device, not covered by Medicare |
| Urethral suppository | Insertion after urinating, tolerance of local burning | Once cleared for sexual activity | Yes | Branded product discontinued in 2024, compounded pricing varies |
| Penile injections | Self-injection, dose titration, clinic training | Once cleared, after training visits | Yes | About $3,947 a year for branded alprostadil, Trimix priced separately |
| Rehabilitation program | Daily or scheduled use over months | Usually begun in the first weeks | Usually | No standard bundle, it is the sum of its parts |
| Pelvic floor therapy | Regular sessions and home exercises | Often before surgery and immediately after | Referral for formal therapy | Varies locally, Medicare Part B may apply |
| Shockwave therapy | A course of clinic visits | Any time, investigational status | Provider-administered | About $3,445 per course, no established coverage |
| External penile prosthesis | No erection, no drug, no recovery window, just the device and lubricant | Once cleared for sexual activity | No | $299 to $525 for standard RX Sleeve models, FSA and HSA eligible |
The cost column comes from a 2024 peer-reviewed Medicare cost model built on 2022 prices. That study was funded by a penile implant manufacturer and several authors were employees, so treat the figures as dated benchmarks rather than quotes, and never as a ranking of value. One thing the table does not show is time. The annual figures repeat every year. A device bought once does not.
Yes, and several combinations are complementary rather than competing. A man can pursue erectile recovery with one approach and still have sex in the meantime using another. That is a practical inference rather than trial evidence, and nobody has shown that adding an external device improves rehabilitation outcomes, so do not let anyone sell it to you that way.
There are real sequencing rules. Memorial Sloan Kettering specifies spacing between PDE5 medications and injections rather than using both at once. UCSF advises against routinely adding a vacuum device on top of an injected erection, because bruising and bleeding risk rise. Bring the combination you are considering to your urologist rather than assembling it yourself.
Because a sleeve is worn externally, it can often be used alongside other ED approaches, but customers using an implant or prescription treatment should discuss their individual situation with their clinician.
Orgasm does not require an erection. The two are controlled separately, and pleasure can persist even when penetration is not possible. The American Cancer Society explains that because radical prostatectomy removes the prostate and seminal vesicles, orgasm afterwards is normally dry. No semen is expelled. That is permanent and it is not a sign that anything is wrong.
Intensity often changes. In a study of 145 sexually active men after robot-assisted prostatectomy, 22.8% reported being unable to reach orgasm and 57.2% reported reduced orgasm intensity. Painful orgasm is less common and usually improves. A series of 702 men reported it in about 12%, falling to roughly 7% by 24 months. Pain that persists is worth raising with your urologist rather than pushing through.
A man who believes that no erection means no pleasure stops trying, then stops touching his partner at all, and the problem grows into something much harder to fix than the original nerve injury.
Leaking urine at orgasm is common after prostatectomy, and most men have never heard the word for it before it happens to them.
A systematic review of 5,208 patients found a pooled prevalence of 27.2%. A survey of 1,288 men reported it in 20.8% of all respondents, or around 38.8% of the sexually active group, and 86% of the affected men were otherwise fully continent. That 86% figure explains why climacturia blindsides men. You can be dry all day and still leak at orgasm. The much wider range quoted elsewhere is mostly an artifact of which group was counted.
According to the AUA and SUFU incontinence guideline, risk tracks with time since surgery, prior TURP, and shorter functional urethral and penile length, while age, preoperative erectile function, and nerve-sparing status do not significantly affect it.
Practical management is straightforward. Empty your bladder before sex. A condom contains the leakage. Pelvic floor training helps. A clinician-selected adjustable loop or band is an option. A fully enclosed external prosthesis also contains it, which is why a number of our post-surgical customers buy one. Containment handles the moment but does nothing about the underlying leak, so persistent leakage deserves proper evaluation.
The measurement men panic about is taken at the worst possible moment. In a two-year rehabilitation cohort at NorthShore University HealthSystem, mean stretched penile length was 1.76 cm shorter at one month after surgery and had returned to within 0.5 cm of baseline by six months. If you are four weeks post-op and measuring, you are looking at the low point.
Some loss does persist. A prospective study of 124 men found that 19% of the measured subgroup had a decrease of at least 15% in stretched length. Perceived shortening is reported far more often than measured shortening, which is part of why the numbers you see online vary so wildly. Flaccid, stretched, erect, and perceived measurements are four different things, and a lot of the alarming statistics online come from mixing them together. We have written more on penile shrinkage and what causes it.
On prevention, the figure you will see quoted is that 97% of consistent vacuum device users maintain their preoperative length. The underlying study is narrower than the claim. Of 36 men who used the device on more than half of their prescribed days, only one lost at least 1 cm at three months, so 35 of 36 avoided that degree of loss. That is a threshold result at three months in a small group with a historical comparison, not proof that pumps prevent shrinkage in 97% of men. Daily tadalafil's 4.1 mm average advantage in REACTT is the other length-related finding with real support behind it.
If length has changed, internal fit is what decides whether an external device works well for you. An adjustable inner rod fills the space between the tip of the penis and the end of the internal chamber, which keeps everything solid through penetration. We treat it as standard advice for post-surgical men rather than an accessory.
The conversation is harder than any of the equipment, and it is where we see the most damage done.
What usually happens is that a man stops initiating. Then he stops reaching over in bed at all, because every touch feels like the opening move in something he cannot finish. From the other side of the bed, that reads as rejection or as lost attraction. Months of that do more harm to a relationship than the surgery did.
A few things that help.
In a randomized trial of 142 couples offered an online sexual recovery program, the primary sexual satisfaction outcome did not differ significantly from the control group at six months, but the intervention couples reported more sexual activity at three months. A second trial of 189 couples found increased use of ED treatments at 12 months without significant effects on sexual function or relationship measures.
Structured couples support reliably produces more sexual activity sooner. It does not promise that either of you will feel better about it, and a couple who struggles has not failed at adapting. Referral to a qualified sexual health counselor is a legitimate option in its own right, and it does not imply anyone thinks this is in your head.
If you are the partner reading this first, which happens often, the most useful thing you can do is raise it. He has probably been waiting for permission.
Most men are cleared somewhere around four to six weeks after surgery, though your surgeon sets your date based on how you are healing. Being cleared to resume activity is not the same as having function return.
Yes. Erection and orgasm are controlled separately, so orgasm remains possible without one, though it will be dry because the prostate and seminal vesicles have been removed.
No. Vacuum erection devices and their accessories have been statutorily non-covered under standard Medicare since July 1, 2015, so plan on paying out of pocket.
Branded MUSE was discontinued by Viatris in June 2024 and its three strengths were listed as unavailable in August 2024. Compounded urethral preparations are different products and need to be discussed with your prescriber.
Often, yes. Injections act directly on the erectile tissue rather than amplifying a nerve signal, which is why they remain an option when pills have stopped working.
There is no wear duration limit on a sleeve, because it does not restrict blood flow. The 30-minute rule you will see quoted applies to the constriction ring used with a vacuum pump.
Because a sleeve is worn externally, it can often be used alongside other ED approaches, but customers using an implant or prescription treatment should discuss their individual situation with their clinician.
Sensation varies from man to man and depends on post-surgical status, the treatments you have had, and blood flow. Many men report meaningful stimulation, but nobody can promise you a specific result.
Yes. That is what the firm material is built for. The sleeve supplies the rigidity, the harness holds it in place, and nothing about it depends on blood flow or a nerve signal.
Years rather than months, with routine cleaning and care. Platinum-cured silicone is non-porous and does not break down the way cheaper materials do.
There is no established Medicare coverage determination for this category. They are FSA, HSA, and HRA eligible, which is how most of our customers pay for them.
If you have not yet worked through the medical options with a urologist who takes sexual recovery seriously, start there. Injections in particular are underused, and a man whose surgery took both nerve bundles deserves to hear about them properly rather than being handed another prescription for a pill that was never going to work.
Worth asking at that appointment:
If you have already been down that road, or you want something you can use tonight while the rest plays out, that is the gap we have spent twenty years building for. Our devices do not treat erectile dysfunction and do not repair a nerve. What they do is let you have sex while you live with the consequences of an operation that saved your life.
You can see the full range of our penis sleeves here, or email us and tell us what your surgery was and where you are in recovery. Dan reads those. Twenty years in, there is not much we have not been asked.
*In compliance with: In Vitro EpiDerm™ OECD TG 439 & EpiVaginal™ In Vitro Toxicity
